Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc.

NASDAQ:CTXR

Overview | Financials
Company Name Citius Pharmaceuticals, Inc.
Symbol CTXR
Currency USD
Price 3.56
Market Cap 30,155,834
Dividend Yield 0%
52-week-range 2.44 - 26.75
Industry Biotechnology
Sector Healthcare
CEO Mr. Leonard L. Mazur
Website https://www.citiuspharma.com

An error occurred while fetching data.

About Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related

Related Stocks

Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc.

OVID

0.757 USD

DarioHealth Corp. logo

DarioHealth Corp.

DRIO

0.692 USD

Assertio Holdings, Inc. logo

Assertio Holdings, Inc.

ASRT

0.797 USD

IO Biotech, Inc. logo

IO Biotech, Inc.

IOBT

0.829 USD

Ikena Oncology, Inc. logo

Ikena Oncology, Inc.

IKNA

1.51 USD

AVITA Medical, Inc. logo

AVITA Medical, Inc.

RCEL

9.96 USD

Cue Biopharma, Inc. logo

Cue Biopharma, Inc.

CUE

1.22 USD

Financials

Numbers are in millions USD

Numbers are in millions USD